The future of super-antibody drugs

What went wrong in the recent clinical trial disaster where six men ended on intensive care after getting ill during aclinical drugs trial in London? news article

In the "Can super-antibody drugs be tamed?" Michael Hopkin looks at what went wrong, and whether there is any future for 'superagonist' antibody therapies.